Women's Health

Despite diagnoses of hepatitis C virus and cirrhosis in mothers, many infants are not tested within guidelines for possible transmission, according to a presentation at The Digital Liver Meeting Experience.

During the menopausal transition, women have an increased prevalence of cardiometabolic and CV risk factors; however, data on early preventive strategies are lacking, according to a new statement from the American Heart Association.

Risk for subsequent HF or death in the 5 years after STEMI or non-STEMI remains higher in women, compared with men, researchers reported in Circulation.

Contraceptive use may optimize women’s mental and reproductive health, according to study results published in American Journal of Psychiatry.

Despite guidelines to ensure proper screening, one study presented during the Liver Meeting Digital Experience showed only 42% of infants born to women with hepatitis C and cirrhosis are screened and followed for hepatitis C.

In the United States, the FDA required that the drug mifepristone, an approved medication for nonsurgical abortion, be dispensed only in hospitals, clinics or physician offices, even during the pandemic.

The prevalence of constipation among women was two- to threefold higher during pregnancy and for the first few days postpartum, researchers wrote in the British Journal of Obstetrics and Gynecology.

A keynote speech at the virtual Cardiometabolic Health Congress focused on advances in the use of genetics, artificial intelligence and SGLT2 inhibitors in cardiometabolic care. It was the top story in cardiology last week.

Several reproductive factors, including preeclampsia, preterm birth and early menopause, may increase risk for CVD in women, researchers found.

The loss of estrogen’s protective role in exercise capacity could contribute to the gender gap in overall health between men and women with cystic fibrosis, a presenter at the North American Cystic Fibrosis Conference suggested.